» Articles » PMID: 30079302

Allergic Bronchopulmonary Mycosis - Pathophysiology, Histology, Diagnosis, and Treatment

Overview
Publisher Wolters Kluwer
Date 2018 Aug 7
PMID 30079302
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic bronchopulmonary mycosis (ABPM) develops mainly in patients with asthma or cystic fibrosis via types I and III hypersensitivity reactions to filamentous fungi. spp., especially , is the major causative fungus because of its small conidia, thermophilic hyphae, and ability to secrete serine proteases. The cardinal histological feature of ABPM is allergic (eosinophilic) mucin-harboring hyphae in the bronchi, for which the formation of extracellular DNA trap cell death (ETosis) of eosinophils induced by viable fungi is essential. Clinically, ABPM is characterized by peripheral blood eosinophilia, increased IgE levels in the serum, IgE and IgG antibodies specific for fungi, and characteristic radiographic findings; however, there are substantial differences in the clinical features of this disease between East and South Asian populations. Systemic corticosteroids and/or antifungal drugs effectively control acute diseases, but recurrences are quite common, and development of novel treatments are warranted to avoid adverse effects and emergence of drug-resistance due to prolonged treatment with corticosteroids and/or antifungal drugs.

Citing Articles

Refractory phenotype of -sensitized asthma with bronchiectasis and allergic bronchopulmonary aspergillosis.

Nomura N, Matsumoto H, Asano K, Hayashi Y, Yokoyama A, Nishimura Y J Allergy Clin Immunol Glob. 2024; 4(1):100364.

PMID: 39659740 PMC: 11629325. DOI: 10.1016/j.jacig.2024.100364.


Allergic Bronchopulmonary Candidiasis: An Uncommon Case of Hypereosinophilia.

Mora Pinilla J, Garcia Garcia A, Matesanz Lopez C, Raboso Moreno B Open Respir Arch. 2024; 6(4):100370.

PMID: 39650746 PMC: 11625117. DOI: 10.1016/j.opresp.2024.100370.


A Case of Allergic Bronchopulmonary Mycosis Caused by Cordyceps farinosa, a Species of Caterpillar Fungi.

Sakano Y, Okumura T, Kofuku T, Kidaka S, Nakata Y, Katsura S Cureus. 2024; 16(9):e68366.

PMID: 39355473 PMC: 11443473. DOI: 10.7759/cureus.68366.


Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?.

Asano K, Oguma T Intern Med. 2024; 64(4):493-501.

PMID: 39231658 PMC: 11904459. DOI: 10.2169/internalmedicine.4386-24.


Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis.

Hamakawa M, Ishida T Respirol Case Rep. 2024; 12(4):e01354.

PMID: 38617121 PMC: 11009483. DOI: 10.1002/rcr2.1354.


References
1.
Fukutomi Y, Taniguchi M . Sensitization to fungal allergens: Resolved and unresolved issues. Allergol Int. 2015; 64(4):321-31. DOI: 10.1016/j.alit.2015.05.007. View

2.
Ueki S, Tokunaga T, Fujieda S, Honda K, Hirokawa M, Spencer L . Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation. Curr Allergy Asthma Rep. 2016; 16(8):54. PMC: 5313036. DOI: 10.1007/s11882-016-0634-5. View

3.
Ueki S, Konno Y, Takeda M, Moritoki Y, Hirokawa M, Matsuwaki Y . Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes. J Allergy Clin Immunol. 2015; 137(1):258-267. PMC: 4674385. DOI: 10.1016/j.jaci.2015.04.041. View

4.
Denning D, Pleuvry A, Cole D . Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2012; 51(4):361-70. DOI: 10.3109/13693786.2012.738312. View

5.
Ueki S, Melo R, Ghiran I, Spencer L, Dvorak A, Weller P . Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood. 2013; 121(11):2074-83. PMC: 3596967. DOI: 10.1182/blood-2012-05-432088. View